4
Changes in Ownership
Dyne Therapeutics, Inc. Filed Acc 0000950170-25-038750
Chief Commercial Officer sold 143 shares at $12.12 ($1,733)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Friedl-Naderer Johanna · Chief Commercial Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-03-13 | Sale : show line 1 in the form 10b5-1 | −143 | $12.12 | $1,733 | 96,057 | D |
| Open-market sales · 143 sh · avg $12.12 · $1,733 | ||||||
Loading xslF345X05/ownership.xml…